English | Español
Kathy Adams | Mar 1, 2016

FDA approves XELJANZ XR as once-daily arthritis treatment
Amanda Rupp | Mar 1, 2016

FDA approves drug for gastrointestinal, NET tumors
Whitney Wright | Mar 1, 2016

CMS updates questions concerning EHR incentive program
Kerry Goff | Mar 1, 2016

UIC researcher believes new health care trends include high deductibles, 'value' ambiguity
Kerry Goff | Mar 1, 2016

Rice University public policy director details effects of Obamacare
Kerry Goff | Feb 28, 2016

ER drug shortages getting worse with more FDA regulations
Jamie Barrand | Feb 27, 2016

Educator pens book on how to help autistic children manage stress
Jamie Barrand | Feb 27, 2016

New campaign attempts to stem opioid abuse in Massachusetts

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'